Literature DB >> 8913489

Antimicrobial susceptibility pattern of Corynebacterium striatum.

L Martínez-Martínez1, A Pascual, K Bernard, A I Suárez.   

Abstract

The in vitro activities of 16 antimicrobial agents against 86 strains of Corynebacterium striatum were evaluated by microdilution using cation-adjusted Mueller-Hinton broth. MICs at which 90% of strains were inhibited were 0.06 microgram/ml for teicoplanin, 1 microgram/ml for vancomycin, 0.03 to 8 micrograms/ml for beta-lactams, 8 micrograms/ml for sparfloxacin, 16 micrograms/ml for ciprofloxacin, 16/304 micrograms/ml for co-trimoxazole (trimethoprim-sulfamethoxazole), 64 micrograms/ml for tetracycline, 128 micrograms/ml for gentamicin, and > 128 micrograms/ml for amikacin, erythromycin, and rifampin.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8913489      PMCID： PMC163600     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

Review 1.  Coryneform bacteria in infectious diseases: clinical and laboratory aspects.

Authors:  M B Coyle; B A Lipsky
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

2.  In vitro susceptibility of Corynebacterium group D2 and Corynebacterium jeikeium to twelve antibiotics.

Authors:  A Philippon; F Bimet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-12       Impact factor: 3.267

3.  In vitro activity of ciprofloxacin against group JK corynebacteria.

Authors:  K Machka; H Balg
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

4.  Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents.

Authors:  F Soriano; J Zapardiel; E Nieto
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

5.  Comparative in vitro activities of new quinolones against coryneform bacteria.

Authors:  L Martínez-Martínez; A I Suárez; M C Ortega; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

6.  Susceptibility of urinary isolates of Corynebacterium group D2 to fifteen antimicrobials and acetohydroxamic acid.

Authors:  F Soriano; C Ponte; M Santamaría; A Torres; R Fernández-Roblas
Journal:  J Antimicrob Chemother       Date:  1987-09       Impact factor: 5.790

7.  Corynebacterium striatum: a diphtheroid with pathogenic potential.

Authors:  D A Watkins; A Chahine; R J Creger; M R Jacobs; H M Lazarus
Journal:  Clin Infect Dis       Date:  1993-07       Impact factor: 9.079

8.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

9.  Characterization of antibiotic-resistant Corynebacterium striatum strains.

Authors:  M C Roberts; R B Leonard; A Briselden; F D Schoenknecht; M B Coyle
Journal:  J Antimicrob Chemother       Date:  1992-10       Impact factor: 5.790

10.  Phenotypic characteristics of 31 strains of Corynebacterium striatum isolated from clinical samples.

Authors:  L Martínez-Martínez; A I Suárez; J Winstanley; M C Ortega; K Bernard
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948
View more
  14 in total

1.  Native valve endocarditis caused by Corynebacterium striatum with heterogeneous high-level daptomycin resistance: collateral damage from daptomycin therapy?

Authors:  Truc T Tran; Siraya Jaijakul; Cole T Lewis; Lorena Diaz; Diana Panesso; Heidi B Kaplan; Barbara E Murray; Audrey Wanger; Cesar A Arias
Journal:  Antimicrob Agents Chemother       Date:  2012-03-26       Impact factor: 5.191

2.  Activities of gemifloxacin and five other antimicrobial agents against Listeria monocytogenes and coryneform bacteria isolated from clinical samples.

Authors:  L Martínez-Martínez; P Joyanes; A I Suárez; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

3.  Relationship between mutations in the gyrA gene and quinolone resistance in clinical isolates of Corynebacterium striatum and Corynebacterium amycolatum.

Authors:  Josep M Sierra; Luis Martinez-Martinez; Fernando Vázquez; Ernest Giralt; Jordi Vila
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

4.  In vitro activities of ketolide HMR 3647, macrolides, and clindamycin against Coryneform bacteria.

Authors:  L Martínez-Martínez; A Pascual; A I Suárez; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

5.  Corynebacterium striatum empyema and osteomyelitis in a patient with advanced rheumatoid arthritis.

Authors:  Rajanshu Verma; Gary R Kravitz
Journal:  BMJ Case Rep       Date:  2016-03-04

6.  In Vitro Antibiotic Susceptibility Pattern of Non-diphtheriae Corynebacterium Isolates in Ontario, Canada, from 2011 to 2016.

Authors:  Julianne V Kus; Samir N Patel; Alefiya Neemuchwala; Deidre Soares; Vithusha Ravirajan; Alex Marchand-Austin
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

7.  Activities of ABT-773 against Listeria monocytogenes and coryneform bacteria of clinical interest.

Authors:  María del Carmen Conejo; Luis Martínez-Martínez; Alvaro Pascual; Ana Isabel Suárez; Evelio J Perea
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

8.  Clinical characteristics and drug susceptibility patterns of Corynebacterium species in bacteremic patients with hematological disorders.

Authors:  Masahiro Abe; Muneyoshi Kimura; Hideyuki Maruyama; Tomohisa Watari; Sho Ogura; Shinsuke Takagi; Naoyuki Uchida; Yoshihito Otsuka; Shuichi Taniguchi; Hideki Araoka
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-04-24       Impact factor: 3.267

9.  Multidrug-Resistant Corynebacterium striatum Associated with Increased Use of Parenteral Antimicrobial Drugs.

Authors:  William O Hahn; Brian J Werth; Susan M Butler-Wu; Robert M Rakita
Journal:  Emerg Infect Dis       Date:  2016-11       Impact factor: 6.883

10.  Clonal multidrug-resistant Corynebacterium striatum within a nosocomial environment, Rio de Janeiro, Brazil.

Authors:  Paulo Victor Pereira Baio; Higor Franceschi Mota; Andréa D'avila Freitas; Débora Leandro Rama Gomes; Juliana Nunes Ramos; Lincoln Oliveira Sant'Anna; Mônica Cristina Souza; Thereza Cristina Ferreira Camello; Raphael Hirata Junior; Verônica Viana Vieira; Ana Luíza Mattos-Guaraldi
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-02       Impact factor: 2.743
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.